Back
Edgewise Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
EWTX
Edgewise Therapeutics
Last Price:
$29.63
Seasonality Move:
26.98%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EWTX is experiencing slight buying pressure.
Edgewise Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.2 | Sell |
| 20-day SMA: | 30.81 | Sell |
| 50-day SMA: | 32.64 | Sell |
| 200-day SMA: | 22.49 | Buy |
| 8-day EMA: | 30.19 | Sell |
| 20-day EMA: | 30.74 | Sell |
| 50-day EMA: | 30.54 | Sell |
| 200-day EMA: | 23.69 | Buy |
Edgewise Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.57 | Sell |
| Relative Strength Index (14 RSI): | 44.56 | Sell |
| Chaikin Money Flow: | 1558 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.66 - 32.42) | Sell |
| Bollinger Bands (100): | (20.17 - 33.79) | Buy |
Edgewise Therapeutics Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Edgewise Therapeutics Stock
Is Edgewise Therapeutics Stock a Buy?
-
Edgewise Therapeutics share price is 29.62 while EWTX 8-day simple moving average is 30.20, which is a Sell signal.
-
The stock price of EWTX is 29.62 while Edgewise Therapeutics 20-day SMA is 30.81, which makes it a Sell.
-
Edgewise Therapeutics 50-day simple moving average is 32.64 while EWTX share price is 29.62, making it a Sell technically.
-
EWTX stock price is 29.62 and Edgewise Therapeutics 200-day simple moving average is 22.49, creating a Buy signal.
EWTX Technical Analysis vs Fundamental Analysis
Sell
46
Edgewise Therapeutics (EWTX)
is a Sell
Is Edgewise Therapeutics a Buy or a Sell?
-
Edgewise Therapeutics stock is rated a SellThe current Edgewise Therapeutics [EWTX] share price is $29.62. The Score for EWTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Edgewise Therapeutics Stock Info
Market Cap:
2.8B
Price in USD:
29.62
Share Volume:
378.7K
Edgewise Therapeutics 52-Week Range
52-Week High:
38.12
52-Week Low:
9.00
Sell
46
Edgewise Therapeutics (EWTX)
is a Sell
Edgewise Therapeutics Share Price Forecast
-
What is the Edgewise Therapeutics stock price today?The Edgewise Therapeutics stock price is 29.62 USD today.
-
Will EWTX stock go up or go down?Edgewise Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Edgewise Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Edgewise Therapeutics is overvalued.
Is Edgewise Therapeutics Stock a Buy?
-
Edgewise Therapeutics share price is 29.62 while EWTX 8-day exponential moving average is 30.19, which is a Sell signal.
-
The stock price of EWTX is 29.62 while Edgewise Therapeutics 20-day EMA is 30.74, which makes it a Sell.
-
Edgewise Therapeutics 50-day exponential moving average is 30.54 while EWTX share price is 29.62, making it a Sell technically.
-
EWTX stock price is 29.62 and Edgewise Therapeutics 200-day simple moving average is 23.69, creating a Buy signal.
Fundamental Analysis of Edgewise Therapeutics
Is Edgewise Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.30 per share.
Technical Analysis of Edgewise Therapeutics
Should I short Edgewise Therapeutics stock?
-
EWTX Moving Average Covergence Divergence (MACD) indicator is -0.57, suggesting Edgewise Therapeutics is a Sell
-
Edgewise Therapeutics Relative Strength Index (RSI) is 44.56, which suggest Edgewise Therapeutics is oversold
-
The Bollinger Bands (25) for Edgewise Therapeutics is (29.66 - 32.42), which suggest Edgewise Therapeutics is a Buy
-
The Bollinger Bands (100) for Edgewise Therapeutics is (20.17 - 33.79), which suggest Edgewise Therapeutics is a Buy
* Edgewise Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.